
Artificial Pancreas Device System Market
Description
Artificial Pancreas Device System Market
Pancreas is one of the major endocrine gland which secretes hormones released directly into the blood. Pancreas is around 6 inches long located in the abdominal cavity. Pancreas produce the vital hormones of insulin, pancreatic polypeptide, glucagon and somatostatin. Pancreas aid in digestion and absorption processes by secreting the pancreatic juice which contains digestive enzymes. The Artificial Pancreas Device System is used in the treatment of Type 1 Diabetes. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. The Artificial Pancreas Device System is also referred to as the closed-loop system or autonomous system for glycemic control or bionic pancreas. The Artificial Pancreas Device System simulates the glucose regulation function of a healthy pancreas. The continuous glucose monitoring is done by placing the sensor subcutaneously to measure the glucose level in the fluid around the cells. A transmitter sends information of glucose level estimates and their rate of change to the receiver. Control algorithm software embedded in an external controller performs mathematical calculations to send dosing instruction to the insulin infusion pumps, computer or smartphone. Depending on the dosing instructions, the insulin infusion pump regulates the level of insulin delivery to the subcutaneous tissue.
Artificial Pancreas Device System Market: Drivers & Restraints
The Food and Drug Administration (FDA) is collaborating with private and government research institutions to improvise clinical studies and accelerate the development of the Artificial Pancreas Device Systems. In October 2012, the FDA released a document on requirements of clinical studies and premarket approval applications for the production Artificial Pancreas Device Systems. This will encourage the manufacturing of Artificial Pancreas Device Systems and drive the growth of the global Artificial Pancreas Device System market. The patients need to calibrate the continuous glucose monitor at equal intervals. Also, the continuous glucose monitoring sensors are subjected to biofouling and fibrosis when they are placed subcutaneously which alters the productivity of sensors. The FDA has identified issues in the components and software of insulin infusion pumps. The insulin used currently in the Artificial Pancreas Device Systems takes longer duration of time to completely absorb. Such factors related to Artificial Pancreas Device Systems could potentially hamper the growth of the global Artificial Pancreas Device Systems market.
Artificial Pancreas Device System Market: Segmentation
Artificial Pancreas Device System market is classified on the basis product type and geography.
Based on product type, the global Artificial Pancreas Device System market is segmented into the following:
Threshold Suspend Device System
Control-to-Range (CTR) System
Control -to-Target (CTT) System
Artificial Pancreas Device System Market: Overview
The concentration of glucose in the blood of the patient is very dynamic and is affected by the patient’s physical activity and diet. The Artificial Pancreas Device System helps in the sustenance of life of type 1 diabetes patients. The Artificial Pancreas Device System does the function of beta cells of a healthy pancreas. Type 1 diabetes patient have to closely monitor blood glucose levels in order to avoid hyperglycemia and hypoglycemia which leads to long-term diabetes complications such as seizures, coma and even death. Thus, blood glucose monitoring on a daily basis is essential and the Artificial Pancreas Device System is the solution to it.
Artificial Pancreas Device System Market: Region-wise Outlook
Depending on geographic regions, global Artificial Pancreas Device System market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. India, China, USA, Indonesia, Pakistan and Japan are the top six countries with the highest number of estimated cases of diabetes. As a result, Asia Pacific and North America are anticipated to be the potential markets for the global Artificial Pancreas Device System market players.
Artificial Pancreas Device System Market: Key Players
Some of the key market players in global Artificial Pancreas Device System market are Pancreum, LLC, Medtronic, Inc. and JDRF. In the near future, the global Artificial Pancreas Device System manufacturers have to develop products which will not only monitor but also adjust the blood glucose levels rapidly without the need of intervention of the patient.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Rest of Western Europe)
Eastern Europe (Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Product Life Cycle Analysis
- 3.5. Supply Chain Analysis
- 3.5.1. Supply Side Participants and their Roles
- 3.5.1.1. Producers
- 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
- 3.5.1.3. Wholesalers and Distributors
- 3.5.2. Value Added and Value Created at Node in the Supply Chain
- 3.5.3. List of Raw Material Suppliers
- 3.5.4. List of Existing and Potential Buyer’s
- 3.6. Investment Feasibility Matrix
- 3.7. Value Chain Analysis
- 3.7.1. Profit Margin Analysis
- 3.7.2. Wholesalers and Distributors
- 3.7.3. Retailers
- 3.8. PESTLE and Porter’s Analysis
- 3.9. Regulatory Landscape
- 3.9.1. By Key Regions
- 3.9.2. By Key Countries
- 3.10. Regional Parent Market Outlook
- 3.11. Production and Consumption Statistics
- 3.12. Import and Export Statistics
- 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
- 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
- 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2017-2021
- 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2022-2032
- 5.3.1. Threshold Suspended Device System
- 5.3.2. Insulin-Only System
- 5.3.3. Bi-Hormonal Control System
- 5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
- 5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
- 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
- 6.3.1. Hospitals
- 6.3.2. Clinics
- 6.3.3. Others
- 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
- 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
- Deep-dive segmentation will be available in the sample on request
- 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
- 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. East Asia
- 7.3.5. South Asia & Pacific
- 7.3.6. MEA
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 8.2.1. By Country
- 8.2.1.1. U.S.
- 8.2.1.2. Canada
- 8.2.2. By Type
- 8.2.3. By End User
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Type
- 8.3.3. By End User
- 8.4. Key Takeaways
- 9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Rest of Latin America
- 9.2.2. By Type
- 9.2.3. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By End User
- 9.4. Key Takeaways
- 10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. U.K.
- 10.2.1.3. France
- 10.2.1.4. Spain
- 10.2.1.5. Italy
- 10.2.1.6. Rest of Europe
- 10.2.2. By Type
- 10.2.3. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By End User
- 10.4. Key Takeaways
- 11. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.2. By Type
- 11.2.3. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Type
- 11.3.3. By End User
- 11.4. Key Takeaways
- 12. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 12.2.1. By Country
- 12.2.1.1. India
- 12.2.1.2. Thailand
- 12.2.1.3. Indonesia
- 12.2.1.4. Malaysia
- 12.2.1.5. Singapore
- 12.2.1.6. Australia
- 12.2.1.7. New Zealand
- 12.2.1.8. Rest of South Asia & Pacific
- 12.2.2. By Type
- 12.2.3. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Type
- 12.3.3. By End User
- 12.4. Key Takeaways
- 13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
- 13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
- 13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
- 13.2.1. By Country
- 13.2.1.1. GCC Countries
- 13.2.1.2. South Africa
- 13.2.1.3. Israel
- 13.2.1.4. Rest of MEA
- 13.2.2. By Type
- 13.2.3. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Type
- 13.3.3. By End User
- 13.4. Key Takeaways
- 14. Key Countries Market Analysis
- 14.1. U.S.
- 14.1.1. Pricing Analysis
- 14.1.2. Market Share Analysis, 2021
- 14.1.2.1. By Type
- 14.1.2.2. By End User
- 14.2. Canada
- 14.2.1. Pricing Analysis
- 14.2.2. Market Share Analysis, 2021
- 14.2.2.1. By Type
- 14.2.2.2. By End User
- 14.3. Brazil
- 14.3.1. Pricing Analysis
- 14.3.2. Market Share Analysis, 2021
- 14.3.2.1. By Type
- 14.3.2.2. By End User
- 14.4. Mexico
- 14.4.1. Pricing Analysis
- 14.4.2. Market Share Analysis, 2021
- 14.4.2.1. By Type
- 14.4.2.2. By End User
- 14.5. Germany
- 14.5.1. Pricing Analysis
- 14.5.2. Market Share Analysis, 2021
- 14.5.2.1. By Type
- 14.5.2.2. By End User
- 14.6. U.K.
- 14.6.1. Pricing Analysis
- 14.6.2. Market Share Analysis, 2021
- 14.6.2.1. By Type
- 14.6.2.2. By End User
- 14.7. France
- 14.7.1. Pricing Analysis
- 14.7.2. Market Share Analysis, 2021
- 14.7.2.1. By Type
- 14.7.2.2. By End User
- 14.8. Spain
- 14.8.1. Pricing Analysis
- 14.8.2. Market Share Analysis, 2021
- 14.8.2.1. By Type
- 14.8.2.2. By End User
- 14.9. Italy
- 14.9.1. Pricing Analysis
- 14.9.2. Market Share Analysis, 2021
- 14.9.2.1. By Type
- 14.9.2.2. By End User
- 14.10. China
- 14.10.1. Pricing Analysis
- 14.10.2. Market Share Analysis, 2021
- 14.10.2.1. By Type
- 14.10.2.2. By End User
- 14.11. Japan
- 14.11.1. Pricing Analysis
- 14.11.2. Market Share Analysis, 2021
- 14.11.2.1. By Type
- 14.11.2.2. By End User
- 14.12. South Korea
- 14.12.1. Pricing Analysis
- 14.12.2. Market Share Analysis, 2021
- 14.12.2.1. By Type
- 14.12.2.2. By End User
- 14.13. India
- 14.13.1. Pricing Analysis
- 14.13.2. Market Share Analysis, 2021
- 14.13.2.1. By Type
- 14.13.2.2. By End User
- 14.14. Thailand
- 14.14.1. Pricing Analysis
- 14.14.2. Market Share Analysis, 2021
- 14.14.2.1. By Type
- 14.14.2.2. By End User
- 14.15. Indonesia
- 14.15.1. Pricing Analysis
- 14.15.2. Market Share Analysis, 2021
- 14.15.2.1. By Type
- 14.15.2.2. By End User
- 14.16. Malaysia
- 14.16.1. Pricing Analysis
- 14.16.2. Market Share Analysis, 2021
- 14.16.2.1. By Type
- 14.16.2.2. By End User
- 14.17. Singapore
- 14.17.1. Pricing Analysis
- 14.17.2. Market Share Analysis, 2021
- 14.17.2.1. By Type
- 14.17.2.2. By End User
- 14.18. Australia
- 14.18.1. Pricing Analysis
- 14.18.2. Market Share Analysis, 2021
- 14.18.2.1. By Type
- 14.18.2.2. By End User
- 14.19. New Zealand
- 14.19.1. Pricing Analysis
- 14.19.2. Market Share Analysis, 2021
- 14.19.2.1. By Type
- 14.19.2.2. By End User
- 14.20. GCC Countries
- 14.20.1. Pricing Analysis
- 14.20.2. Market Share Analysis, 2021
- 14.20.2.1. By Type
- 14.20.2.2. By End User
- 14.21. South Africa
- 14.21.1. Pricing Analysis
- 14.21.2. Market Share Analysis, 2021
- 14.21.2.1. By Type
- 14.21.2.2. By End User
- 14.22. Israel
- 14.22.1. Pricing Analysis
- 14.22.2. Market Share Analysis, 2021
- 14.22.2.1. By Type
- 14.22.2.2. By End User
- 15. Market Structure Analysis
- 15.1. Competition Dashboard
- 15.2. Competition Benchmarking
- 15.3. Market Share Analysis of Top Players
- 15.3.1. By Regional
- 15.3.2. By Type
- 15.3.3. By End User
- 16. Competition Analysis
- 16.1. Competition Deep Dive
- 16.1.1. Pancreum, LLC
- 16.1.1.1. Overview
- 16.1.1.2. Product Portfolio
- 16.1.1.3. Profitability by Market Segments
- 16.1.1.4. Sales Footprint
- 16.1.1.5. Strategy Overview
- 16.1.1.5.1. Marketing Strategy
- 16.1.1.5.2. Product Strategy
- 16.1.1.5.3. Channel Strategy
- 16.1.2. Medtronic, Inc.
- 16.1.2.1. Overview
- 16.1.2.2. Product Portfolio
- 16.1.2.3. Profitability by Market Segments
- 16.1.2.4. Sales Footprint
- 16.1.2.5. Strategy Overview
- 16.1.2.5.1. Marketing Strategy
- 16.1.2.5.2. Product Strategy
- 16.1.2.5.3. Channel Strategy
- 16.1.3. JDRF
- 16.1.3.1. Overview
- 16.1.3.2. Product Portfolio
- 16.1.3.3. Profitability by Market Segments
- 16.1.3.4. Sales Footprint
- 16.1.3.5. Strategy Overview
- 16.1.3.5.1. Marketing Strategy
- 16.1.3.5.2. Product Strategy
- 16.1.3.5.3. Channel Strategy
- 16.1.4. Johnson & Johnson
- 16.1.4.1. Overview
- 16.1.4.2. Product Portfolio
- 16.1.4.3. Profitability by Market Segments
- 16.1.4.4. Sales Footprint
- 16.1.4.5. Strategy Overview
- 16.1.4.5.1. Marketing Strategy
- 16.1.4.5.2. Product Strategy
- 16.1.4.5.3. Channel Strategy
- 16.1.5. Beta Bionics, Inc.
- 16.1.5.1. Overview
- 16.1.5.2. Product Portfolio
- 16.1.5.3. Profitability by Market Segments
- 16.1.5.4. Sales Footprint
- 16.1.5.5. Strategy Overview
- 16.1.5.5.1. Marketing Strategy
- 16.1.5.5.2. Product Strategy
- 16.1.5.5.3. Channel Strategy
- 16.1.6. Tandem Diabetes Care
- 16.1.6.1. Overview
- 16.1.6.2. Product Portfolio
- 16.1.6.3. Profitability by Market Segments
- 16.1.6.4. Sales Footprint
- 16.1.6.5. Strategy Overview
- 16.1.6.5.1. Marketing Strategy
- 16.1.6.5.2. Product Strategy
- 16.1.6.5.3. Channel Strategy
- 16.1.7. Insulet Corporation
- 16.1.7.1. Overview
- 16.1.7.2. Product Portfolio
- 16.1.7.3. Profitability by Market Segments
- 16.1.7.4. Sales Footprint
- 16.1.7.5. Strategy Overview
- 16.1.7.5.1. Marketing Strategy
- 16.1.7.5.2. Product Strategy
- 16.1.7.5.3. Channel Strategy
- 16.1.8. Bigfoot Biomedical, Inc.
- 16.1.8.1. Overview
- 16.1.8.2. Product Portfolio
- 16.1.8.3. Profitability by Market Segments
- 16.1.8.4. Sales Footprint
- 16.1.8.5. Strategy Overview
- 16.1.8.5.1. Marketing Strategy
- 16.1.8.5.2. Product Strategy
- 16.1.8.5.3. Channel Strategy
- 16.1.9. Dexcom, Inc.
- 16.1.9.1. Overview
- 16.1.9.2. Product Portfolio
- 16.1.9.3. Profitability by Market Segments
- 16.1.9.4. Sales Footprint
- 16.1.9.5. Strategy Overview
- 16.1.9.5.1. Marketing Strategy
- 16.1.9.5.2. Product Strategy
- 16.1.9.5.3. Channel Strategy
- 16.1.10. Admetsys
- 16.1.10.1. Overview
- 16.1.10.2. Product Portfolio
- 16.1.10.3. Profitability by Market Segments
- 16.1.10.4. Sales Footprint
- 16.1.10.5. Strategy Overview
- 16.1.10.5.1. Marketing Strategy
- 16.1.10.5.2. Product Strategy
- 16.1.10.5.3. Channel Strategy
- 17. Assumptions & Acronyms Used
- 18. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.